Fava V

No ORCID on file · 1 paper in corpus
other 2020
Journal of women's health (2002) ·doi:10.1089/jwh.2020.8291

Background: To evaluate the effects of a 24/4 regimen combined oral contraceptive (COC) containing 1.5 mg 17β-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) compared to on-demand nonsteroidal anti-inflammatory drugs (NSAIDs) on women…